Incannex Healthcare (IXHL) Common Equity (2020 - 2026)

Incannex Healthcare has disclosed Common Equity across 7 years of filings, most recently posting $75.2 million for Q1 2026.

• Common Equity for Q1 2026 came in at $75.2 million, up 916.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $75.2 million (up 916.26% YoY), and the FY2025 annual result was $13.4 million, up 19.36% from the prior year.
• Common Equity came in at $75.2 million for Q1 2026 at Incannex Healthcare, up from $73.4 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $77.0 million in Q3 2025 to a low of $964000.0 in Q4 2024.
• The 5-year median for Common Equity is $19.8 million (2023), against an average of $27.7 million.
• Across the five-year window, Common Equity slumped 94.89% in 2024 and soared 7514.73% in 2025, its largest moves.
• Incannex Healthcare's Common Equity stood at $27.9 million in 2022, then tumbled by 32.39% to $18.9 million in 2023, then plunged by 94.89% to $964000.0 in 2024, then jumped by 7514.73% to $73.4 million in 2025, then rose by 2.49% to $75.2 million in 2026.
• The last three Common Equity figures came in at $75.2 million (Q1 2026), $73.4 million (Q4 2025), and $77.0 million (Q3 2025), per Business Quant data.